Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-apneic Blood Pressure Surge in OSA
NCT06172998Phase 1Recruiting
- Start
- Apr 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of phentolamine and nitroglycerin in obstructive sleep apnea (OSA) (3 arms). Primary endpoint: Number of Participants with high nocturnal short-term BPV will change. Started Apr 2022; status: recruiting.
02
Drugs
phentolaminenitroglycerin
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT06172998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06172998.